Literature DB >> 23428967

Impact of severe sepsis on serum and urinary biomarkers of acute kidney injury in critically ill children: an observational study.

Matteo Di Nardo1, Alessio Ficarella, Zaccaria Ricci, Rosa Luciano, Francesca Stoppa, Sergio Picardo, Stefano Picca, Maurizio Muraca, Paola Cogo.   

Abstract

BACKGROUND/AIMS: We hypothesized that sepsis could have an impact on the sensitivity of serum and urinary neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C (CysC) for acute kidney injury (AKI) diagnosis in critically ill children.
METHODS: Serum NGAL (sNGAL) and urinary NGAL (uNGAL) and CysC were measured daily in the first 48 h from pediatric intensive care unit admission in 11 consecutive critically ill children with severe sepsis; a single measurement was made in a population of 10 healthy controls undergoing minor ambulatory surgery to exclude possible biases in the laboratory methods.
RESULTS: uNGAL, serum CysC (sCysC), and urinary CysC (uCysC) levels were significantly increased in patients with septic AKI compared with septic patients without AKI, while sNGAL levels were not significantly different between septic patients with and without AKI. Median serum creatinine levels did not show significant differences between AKI and non-AKI patients.
CONCLUSIONS: uNGAL, sCysC and uCysC were not altered by sepsis and were good predictors of AKI. In a septic state, sNGAL alone did not discriminate patients with AKI from those without AKI.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23428967     DOI: 10.1159/000346629

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  23 in total

1.  Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants.

Authors:  Bo-Hao Tang; Yue-E Wu; Chen Kou; Yu-Jie Qi; Hui Qi; Hai-Yan Xu; Stephanie Leroux; Xin Huang; Yue Zhou; Yi Zheng; Evelyne Jacqz-Aigrain; A-Dong Shen; Wei Zhao
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 2.  Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment.

Authors:  Sadudee Peerapornratana; Carlos L Manrique-Caballero; Hernando Gómez; John A Kellum
Journal:  Kidney Int       Date:  2019-06-07       Impact factor: 10.612

Review 3.  Clinical approach to the patient with AKI and sepsis.

Authors:  Mélanie Godin; Patrick Murray; Ravindra L Mehta
Journal:  Semin Nephrol       Date:  2015-01       Impact factor: 5.299

4.  Inhibition of histone methyltransferase G9a effectively protected the kidney against ischemia-reperfusion injury.

Authors:  Peihsun Sung; Chihchao Yang; John Y Chiang; Chihhung Chen; Chiwen Luo; Honkan Yip
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

5.  Effect of Cystatin C on Vancomycin Clearance Estimation in Critically Ill Children Using a Population Pharmacokinetic Modeling Approach.

Authors:  Kevin J Downes; Nicole R Zane; Athena F Zuppa
Journal:  Ther Drug Monit       Date:  2020-12       Impact factor: 3.118

6.  Urinary neutrophil gelatinase-associated lipocalin identifies critically ill young children with acute kidney injury following intensive care admission: a prospective cohort study.

Authors:  Alexandra J M Zwiers; Saskia N de Wildt; Joost van Rosmalen; Yolanda B de Rijke; Erik A B Buijs; Dick Tibboel; Karlien Cransberg
Journal:  Crit Care       Date:  2015-04-21       Impact factor: 9.097

7.  Towards a biomarker panel for the assessment of AKI in children receiving intensive care.

Authors:  James McCaffrey; Beatrice Coupes; Chris Chaloner; Nicholas J A Webb; Rachael Barber; Rachel Lennon
Journal:  Pediatr Nephrol       Date:  2015-04-15       Impact factor: 3.714

8.  Bedside biomarkers in pediatric cardio renal injuries in emergency.

Authors:  Noopur Singhal; Abhijeet Saha
Journal:  Int J Crit Illn Inj Sci       Date:  2014-07

9.  Augmented renal clearance implies a need for increased amoxicillin-clavulanic acid dosing in critically ill children.

Authors:  Pieter A J G De Cock; Joseph F Standing; Charlotte I S Barker; Annick de Jaeger; Evelyn Dhont; Mieke Carlier; Alain G Verstraete; Joris R Delanghe; Hugo Robays; Peter De Paepe
Journal:  Antimicrob Agents Chemother       Date:  2015-09-08       Impact factor: 5.191

10.  Serum and urinary NGAL in septic newborns.

Authors:  Mike Smertka; Jolanta Wroblewska; Anna Suchojad; Malgorzata Majcherczyk; Danuta Jadamus-Niebroj; Teresa Owsianka-Podlesny; Aniceta Brzozowska; Iwona Maruniak-Chudek
Journal:  Biomed Res Int       Date:  2014-01-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.